{"id":23486,"date":"2021-05-19T00:00:00","date_gmt":"2021-05-19T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/2021\/05\/19\/des-resultats-prometteurs-pour-la-phase-2-du-vaccin-de-medicago\/"},"modified":"2021-05-19T00:00:00","modified_gmt":"2021-05-19T05:00:00","slug":"des-resultats-prometteurs-pour-la-phase-2-du-vaccin-de-medicago","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2021\/05\/19\/des-resultats-prometteurs-pour-la-phase-2-du-vaccin-de-medicago\/","title":{"rendered":"Des r\u00e9sultats prometteurs pour la phase 2 du vaccin de Medicago"},"content":{"rendered":"<p>Le candidat-vaccin de Medicago contre la COVID-19 a provoqu&eacute; &laquo;&nbsp;une solide&nbsp;&raquo; r&eacute;ponse immunitaire pour les patients ayant re&ccedil;u deux&nbsp;doses dans le cadre de sa deuxi&egrave;me&nbsp;phase d&#39;essai clinique, a annonc&eacute; l&#39;entreprise de Qu&eacute;bec. Lire la suite <a href=\"https:\/\/ici.radio-canada.ca\/nouvelle\/1793907\/resultats-prometteurs-phase-2-vaccin-medicago-covid-19\" target=\"_blank\" rel=\"noopener\">ici<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le candidat-vaccin de Medicago contre la COVID-19 a provoqu&eacute; &laquo;&nbsp;une solide&nbsp;&raquo; r&eacute;ponse immunitaire pour les patients ayant re&ccedil;u deux&nbsp;doses dans le cadre de sa deuxi&egrave;me&nbsp;phase d&#39;essai clinique, a annonc&eacute; l&#39;entreprise de Qu&eacute;bec. Lire la suite ici.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-23486","post","type-post","status-publish","format-standard","hentry","category-actualites-et-nouvelles-au-sujet-de-la-covid-19"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=23486"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23486\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=23486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=23486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=23486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}